Stockreport

scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

scPharmaceuticals Inc.  (SCPH) 
Last scpharmaceuticals inc. earnings: 3/24 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: scpharmaceuticals.com
PDF Generated 1Q 2024 net FUROSCIX® revenue of $6.1 million, despite an estimated 10% impact to doses filled resulting from the Change Healthcare cyberattack Ended 1Q 2024 [Read more]